BIOMAT Database Logo BIOMAT Database Logo

Safety and efficacy of conversion from once daily Sandimmun to twice daily Neoral cyclosporine in renal allograft recipients. 1998

A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Department of Renal Medicine, Singapore General Hospital, Singapore.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients.
November 2000, Transplantation proceedings,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Conversion from Sandimmun to Neoral in stable pediatric renal transplant recipients.
April 1998, Pediatric nephrology (Berlin, Germany),
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
October 2023, Journal of pediatric surgery,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
August 1996, Transplantation proceedings,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
June 1996, Transplantation proceedings,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients.
September 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Kidney Graft Recipients.
September 2016, Transplantation proceedings,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
January 2012, Transplantation proceedings,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Conversion from cyclosporine to azathioprine in renal allograft recipients.
December 1984, Transplantation,
A Vathsala, and W T Lee, and Y M Lu, and K T Woo
Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
August 1998, Transplantation proceedings,
Copied contents to your clipboard!